Wall Street Surges at Open as Vaccine Hopes Fuel Broad Rally; Dow up 284 Pts

Wall Street Surges at Open as Vaccine Hopes Fuel Broad Rally; Dow up 284 Pts

Investing.com  | Dec 01, 2020 14:38

Wall Street Surges at Open as Vaccine Hopes Fuel Broad Rally; Dow up 284 Pts

By Geoffrey Smith 

Investing.com -- U.S. stock markets surged to new record highs at the opening of trade on Tuesday, as optimism over the early roll-outs of vaccines to treat the Covid-19 coronavirus sustained a broad rally in everything from Brazilian iron ore miners to online pet food stocks.

The S&P 500 and Nasdaq Composite both opened at record highs, while the Dow Jones Industrial Average rose back toward the 30,000 level. By 9:35 AM ET (1435 GMT), the Dow was up 284 points or 1.0% at 29,922 points, while the S&P was also up 1.0% and the Nasdaq Composite was up 0.6%.

Helping the gains were reports that a bipartisan group of Senators had drafted a compromise plan to provide some $908 billion in fresh support for the economy, a figure that included $240 billion for state and local governments. That had been a key sticking point in negotiations between Congressional Republicans and Democrats before the election earlier this month. Newswire headlines suggested that Treasury Secretary Steven Mnuchin and House Speaker Nancy Pelosi would speak later at 1 PM ET.

Before that, the session seemed likely to be dominated by testimony in Congress from Mnuchin and Federal Reserve Chairman Jerome Powell, the first time they have appeared together since Mnuchin refused to extend government authority for a handful of lending programs that the Fed had set up at the start of the crisis. 

Among the big initial gainers was Tesla (NASDAQ:TSLA) stock, which rose 3.6% to a new record high after S&P Dow Jones Global Indexes said that the stock would be incorporated into the S&P 500 in one go, rather than over two discrete dates.  Elsewhere, there were more big gains for vaccine makers after Moderna filed in the EU for emergency use authorization of its Covid-19 drug. Moderna (NASDAQ:MRNA) stock rose another 11%, while Pfizer (NYSE:PFE) stock rose 4.2%, a day after it and partner BioNTech (NASDAQ:BNTX) asked the Food and Drug Administration to approve their vaccine.

Apple (NASDAQ:AAPL) stock rose 2.8%, helped by reports that rival Samsung (KS:005930) will discontinue its Galaxy Note smartphone in the new year. That removes some competition for the iPhone maker at the high end of the market.

On the downside, Zoom Video Communications (NASDAQ:ZM) stock, a favorite stay-at-home play for most of this year, tumbled 11.8% after its latest quarterly report - although strong - failed to live up to the rarified expectations of its shareholders. 

However, the day got off to a bright start as research firm IHS Markit said its purchasing managers index for U.S. manufacturing rose in November despite the slowdown in broader economic activity due to the latest wave of the pandemic. The PMI rose to 56.7 from 53.6 in October.

"Although demand for consumer goods remained somewhat subdued, mainly reflecting rising virus infection rates, demand for investment goods such as business equipment and machinery rose especially sharply," IHS Markit said in its release. 

The more closely watched ISM manufacturing index fell, however, to 57.5 from a 20-month high of 59.3.

Related News

Latest comments

Add a Comment
Please wait a minute before you try to comment again.
Write a reply...
Please wait a minute before you try to comment again.

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

English (USA) English (India) English (Canada) English (Australia) English (South Africa) English (Philippines) English (Nigeria) Deutsch Español (España) Español (México) Français Italiano Nederlands Português (Portugal) Polski Português (Brasil) Русский Türkçe ‏العربية‏ Ελληνικά Svenska Suomi עברית 日本語 한국어 简体中文 繁體中文 Bahasa Indonesia Bahasa Melayu ไทย Tiếng Việt हिंदी
Sign out
Are you sure you want to sign out?
Saving Changes


Download the Investing.com App

Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds. Get free top of the line technical analysis/predictors.

Investing.com is better on the App!

More content, faster quotes and charts, and a smoother experience is available only on the App.